Ether substituted imidazopyridines
CA 2488801 A1 · Owner: 3M Innovative Properties Company · Inventors: Jacobsen, John R.; Moseman, Joan T.; Duffy, Daniel E.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Imidazopyridine compounds that contain an ether functionality at the 1position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases. Methods of preparing the compounds and intermediates useful in the preparation of the compounds are also disclosed.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 6, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 6, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 6, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.